Limaprost-d3 Catalog No.:M26610-C 7s)-adamantan-1-yl]methylidene}amino]-N-[(1S)-1-(C-hydroxycarbonimidoyl)-2-phenylethyl]pentanimidic acid

7s)-adamantan-1-yl]methylidene}amino]-N-[(1S)-1-(C-hydroxycarbonimidoyl)-2-phenylethyl]pentanimidic acid

triphosphate forms of the nucleoside analogs are detected in the human cytomegalovirus (HCMV)-infected cells

COC1=CC=C(C=C1OC)C(=O)NCC1C=CC(=CC=1)OCCN(C)C

The blocking Bcr-Abl kinase activity using PD180970 in the human K562 CML cell line resulted in inhibition of Stat5 DNA-binding activity with an IC50 of 5 nM

Limaprost-d3 Catalog No.:M26610-C 7s)-adamantan-1-yl]methylidene}amino]-N-[(1S)-1-(C-hydroxycarbonimidoyl)-2-phenylethyl]pentanimidic acidLimaprost d3 (17,20 dimethyl 2 PGE1 d3) is the deuterium labeled Limaprost. Limaprost (OP1206) is a PGE1 analogue and a potent and orally active vasodilator. Limaprost increases blood flow and inhibits platelet aggregation. Limaprost pain relief, has antianginal effects, and can be used for ischaemic symptoms research. Product information CAS Number: 1263190 37 9 Molecular Weight: 383. 54 Formula: C22H36O5 Chemical Name: (2E) 7 [(1R,2R,3R) 3 hydroxy 2